Challenges for the WHO Programme for International Drug Monitoring Mary Couper, Shanthi Pal, Mitsuko...
-
Upload
randell-oneal -
Category
Documents
-
view
216 -
download
0
description
Transcript of Challenges for the WHO Programme for International Drug Monitoring Mary Couper, Shanthi Pal, Mitsuko...
Challenges for Challenges for tthe WHO Programme for he WHO Programme for International Drug MonitoringInternational Drug Monitoring
Mary Couper, Shanthi Pal, Mitsuko Imai, Mary Couper, Shanthi Pal, Mitsuko Imai, Maria Cuadrillero, Ana GarciaMaria Cuadrillero, Ana Garcia
WHO International Pharmacovigilance Programme Full and Associate members
StrengthsStrengths
Global PV network Global PV network National Centres National Centres MeetingsMeetings
Only available global Only available global database of ADRs database of ADRs
Over 40 years track Over 40 years track record in medicine record in medicine safetysafety
Public health Public health approachapproach
No hidden agendasNo hidden agendas
WeaknessesWeaknesses
Inadequate Inadequate representation in representation in AfricaAfrica
Only Spontaneous Only Spontaneous reportingreporting
no denominator no denominator datadataPoor quality Poor quality reportsreports
Little or no budget Little or no budget
PHPs: Vertical PHPs: Vertical approach approach
OpportunitiesOpportunities
Donor interest in PVDonor interest in PV
New partnersNew partners
Malaria, HIV AIDS, Malaria, HIV AIDS, neglected diseases neglected diseases
•urgent PV needsurgent PV needs
•investing in new investing in new methodsmethods
ThreatsThreats
Lucrative businessLucrative business
Lack of Lack of harmonization harmonization
Duplication of Duplication of efforts efforts
An analysis of pharmacovigilance An analysis of pharmacovigilance activities in 55 low- and middle-activities in 55 low- and middle-income countriesincome countries
– Sten OlssonSten Olssonaa, Shanthi Pal, Shanthi Palbb, Andy , Andy StergachisStergachiscc, Mary Couper, Mary Couperaa
– Drug Safety 2009/2010Drug Safety 2009/2010
(a: WHO CC, Uppsala; b: WHO QSM; c: UWa)(a: WHO CC, Uppsala; b: WHO QSM; c: UWa)
Fig. 6a. Challenges to PV
0
10
20
30
Fig. 6b. Type of Assistance Needed
0
10
20
30
40
3 tiers-approach for 3 tiers-approach for WHOWHO1.1. As beforeAs before
(Spontaneous reporting)(Spontaneous reporting)
Regional trainingsRegional trainings
2.2. More than beforeMore than before(Active surveillance)(Active surveillance)
Tools Tools Handbooks Handbooks Nigeria, Tanzania, GhanaNigeria, Tanzania, Ghana
3.3. As never beforeAs never before Indicators Indicators Fundraising (EuropeAid; BMGF; FP7) Fundraising (EuropeAid; BMGF; FP7) Centres of excellence (Ghana, Morocco) Centres of excellence (Ghana, Morocco) PVSFPVSF
Maintain as the cheapest, easiest, most sustainable method
Cohort event monitoring; ECDD; EML; DTC
Measure, support, optmise